|
|
|
|
|
|
|
Novo Nordisk A/S (NVO)
|
|
48.27 -0.35 (-0.72%)
|
05-23 16:00
|
|
Open:
|
47.81
|
Pre. Close:
|
48.62
|
|
High:
|
48.3
|
Low:
|
47.8
|
|
Volume:
|
1,050,581
|
Market Cap:
|
116308M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
48.372 - 48.71
|
48.71 - 48.97
|
|
Low:
|
46.903 - 47.368
|
47.368 - 47.725
|
|
Close:
|
47.627 - 48.256
|
48.256 - 48.74
|
|
|
|
Technical analysis (as of: 2018-05-23 4:30:17 PM)
|
|
Overall:
|
 
|
|
Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.
|
|
Target:
|
Six months: 57.07 One year: 58.76
|
|
Support:
|
Support1: 46.52 Support2: 38.70
|
|
Resistance:
|
Resistance1:
48.86 Resistance2: 50.31
|
|
Pivot:
|
48.52
|
|
Moving Averages:
|
MA(5): 48.66 MA(20): 48.30 
MA(100): 50.98 MA(250): 48.70
|
|
MACD:
|
MACD(12,26):
Signal(12,26,9): -0.07
|
|
%K %D:
|
%K(14,3): 40.20 %D(3): 47.08
|
|
RSI:
|
RSI(14): 47.57
|
|
52-Week:
|
High: 58.37
Low: 41.03 Change(%): 15.3
|
|
Average Vol(K):
|
3-Month: 136975
10-Days 114975
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.NVO has closed above bottom band by 38.9%. Bollinger Bands are 53.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to NVO's normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend.
|
|
|
Headline News
|
|
2018-05-21T11:57:48-04:00
A Quantitative System To Invest In Quality Stocks
2018-05-18T08:21:17-04:00
Investors bullish on biotechs after Trump drug pricing speech
2018-05-14T12:16:36-04:00
Provention Bio Files For Up To $50 Million IPO
2018-05-11T14:25:19-04:00
Trump speech on drug prices light on specifics
2018-05-11T10:22:19-04:00
Trump plan on drug prices to be announced this afternoon
2018-05-10T06:28:18-04:00
Novo Nordisk: Review Of Key Growth Drivers And Pipeline Candidates
2018-05-08T10:48:26-04:00
Novo Nordisk: An Objective Analysis
2018-05-08T07:41:19-04:00
Emisphere's Solid Future
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
